Vitiligo

Patients with palmoplantar pustulosis (PPP) have an overlapping comorbidity profile with patients with psoriasis vulgaris, according to a study published in JAMA Dermatology. Dong Hyo Kim, M.D., from the Seoul National University College of Medicine in South Korea, and colleagues conducted a nationwide population-based cross-sectional study involving Korean patients diagnosed with PPP, psoriasis vulgaris, or...

If you or someone you know has vitiligo, learning about available treatments like depigmentation therapy can be empowering. This therapy can offer many benefits, but like all treatments, it has its challenges. Here, we’ll explore what a recent study says about the pros and cons of depigmentation therapy. Depigmentation therapy can make a real difference...

Finding the right treatment for vitiligo can be a process. One study looked at two treatments combined with an ultraviolet light therapy called NB-UVB. Both treatments showed promise, with some areas of the body responding better than others.  Both tacrolimus 0.1% ointment and calcipotriol/betamethasone dipropionate showed promising results when combined with ultraviolet light therapy for...

Medically reviewed by Dr. Shani Saks, D.O. on Sept. 3, 2023 If you or someone you know has vitiligo, it may be helpful to recognize its potential effects on sexual health. Recent research has highlighted a connection between the skin condition and sexual dysfunction. Continue reading for insights into the study’s findings and what they might...

Vitiligo is a distinct dermatological condition characterized by the patchy loss of skin pigmentation, resulting in irregular white patches that may vary in size and location. This intriguing phenomenon isn’t merely skin-deep. It also affects the pigment of the hair growing in these regions, causing it to turn white. Vitiligo typically makes its first appearance...

Medically reviewed by Dr. Shani S. Saks, D.O. on August 2, 2023 A recent study examined the prevalence of vitiligo and the quality of life of vitiligo patients in the United States, Japan, and Europe.  Vitiligo is an autoimmune disorder characterized by skin depigmentation, which can significantly impact the quality of life (QoL) of affected...

Medically reviewed by Dr. Shani S. Saks, D.O. on August 2, 2023 A recent case report focused on the development of vitiligo in a 71-year-old African American male with a large-cell, poorly differentiated neuroendocrine tumor while undergoing treatment with atezolizumab.  In recent years, immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by enhancing the immune...

Medically reviewed by Dr. Shani S. Saks, D.O. on August 2, 2023 Two phase 3 trials report significant repigmentation of vitiligo lesions over 52 weeks, though adverse events were common. Vitiligo is a chronic autoimmune disease characterized by skin depigmentation. Ruxolitinib, an inhibitor of Janus kinase 1 and 2, achieved repigmentation during a phase 2...

Medically reviewed by Dr. Samuel Sarmiento, M.D., MPH on August 3, 2023 For treating patients with chronic pruritus, narrowband ultraviolet B was found to be equivalent to broadband ultraviolet B. In inflammatory skin conditions, phototherapy is an important treatment technique. Ultraviolet light therapy may reduce pruritus in people who suffer from chronic pruritus (CP), whether...